Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
About Ipamorelin Research Ipamorelin is a synthetic pentapeptide studied in laboratory environments for its relationship to growth hormone secretagogue receptor (ghrelin receptor) biology
The studies that have been conducted have shown that people with T1D who are overweight or obese have the most benefits from the GP1 agonist category of medications
Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
Stabilized GHRH (Tesamorelin) Tesamorelin is a structurally stabilized GHRH analog with a longer half-life and stronger effect on visceral adipose tissue than older GHRH peptides
